Blog Flex Databases

With Flex Databases Pharmacovigilance, you’ll only need one case, and you can add as many languages to it as you want.

By automating processes, reducing human error, and improving decision-making, AI can help make clinical trials more efficient, effective, and safe.

Clinergy Health Research selects Flex Databases Pharmacovigilance as cost-effective and easy to integrate solution

This September, Pharma Tech Outlook included Flex Databases in Top-10 Pharmacovigilance solutions providers in the UK & Europe.

In this video we talk about the way Flex Databases Pharmacovigilance module helps to save time on case intake.

lients. That’s why to save your time and give you a deeper understanding of how our Pharmacovigilance module work, we are happy to answer the six most frequently asked questions about the system.

Flex Databases is ready to arrange the automated data flow from any eCRF/EDC used by Sponsor or CRO to our Pharmacovigilance module.

Despite the obvious benefits of introducing new technologies in electronic systems for pharmacovigilance, it is necessary to consider the difficulties that a company will face:

As we briefly discussed in the previous chapter, Artificial Intelligence (AI) is used to simulate the processes of a human brain with the help of computer systems. It encompasses various technologies, including rule-following, reasoning – using rules to reach rough or specific conclusions, learning, and self-correction.

Modern pharmacovigilance, like any other process, in 2021 is impossible without technology and automation.

At the very end of winter, Flex Databases signed a contract for CTMS and Pharmacovigilance module implementation with Italian Human & Digital CRO Exom Group.

In 2021 the United Kingdom is moving to its post-Brexit life with new processes, procedures, and laws everywhere, including clinical trials and pharmacovigilance. This piece we dedicate to a simple question – how to move to post-Brexit pharmacovigilance effortlessly and efficiently.